GAEU Consulting supports Colzyx in securing EUR 1 M equity investment from the European Innovation Council Fund (EIC Fund).
The funding is provided within the framework of the EIC Accelerator blended finance support and will be used to accelerate the development of a completely new and innovative wound care and antimicrobial product. The investment of EUR 1M is the first part of an overall investment amount of EUR 3M. The second part will be invested once Colzyx has reached specific development milestones.
- “The role of GAEU in this process has been to support Colzyx in negotiating the terms of the EIC investment contract. This has been a demanding process and we are happy for the successful conclusion of the negotiations”,
says Tomasz Wąsik, MBA, Partner in GAEU Consulting
-“We are very pleased with the professional support we have received from GAEU in this process. They have demonstrated a very good working knowledge of the EIC Fund and provided useful advice during contract negotiations”
says Eskil Söderlind, PhD, MBA, CEO
The EIC Fund provides equity from €0.5m to €15m to breakthrough innovation companies selected for EIC Accelerator blended finance support (grant and equity).
For more information, contact: Tomasz Wąsik, Partner, GAEU Consulting. Phone: +48 696 108 683, e-mail: email@example.com
Colzyx is a biotechnology company focused on wound care. The company develops WOUNDCOM, a new innovative wound dressing that accelerates wound healing while having an antibacterial effect. Colzyx is located at Medicon Village, Lund. Read more at www.colzyx.com.
GAEU Consulting is a leading independent advisor on European Innovation Funding mechanisms, including Horizon Europe, Eureka, Eurostars, Life, EIT and EIB. GAEU supports innovative companies in implementing their business strategies with EU funding as a propelling force. Read more at www.gaeu.com